Evaluation of new and old biomarkers in dogs with degenerative mitral valve disease

BMC Veterinary Research

Table 7 cTnI concentrations in ng/mL for the respective groups at baseline and follow-up examination

Groups	Baseline (n; median [IQR])	Follow-up (n; median [IQR])	P-value
Controls	21; 0.04 [0.03–0.06]	17; 0.05 [0.03–0.07]	NS
Stage B1	41; 0.05 [0.03–0.07]	33; 0.05 [0.04–0.08]	0.0105*
Stage B2	9; 0.05 [0.03–0.08]	12; 0.07 [0.03–0.17]	NS
Stage C	14; 0.24 [0.1–0.93]	7; 0.1 [0.06–0.21]	NS

IQR Interquartile range, NS Non-significant. The p-value denotes the probability of the change in cTnl concentrations with a significant increase from baseline to follow-up examination for each group. * p < 0.05

ISSN: 1746-6148